Ticker · CUSIP 09058V103

BCRX

BIOCRYST PHARMACEUTICALS INC
···Share
Holders (tracked)
14
Combined shares
14,540,891
Combined value
$112.04M
Last close
$9.52
Quarter
2025Q4
Tracked holders · last 8 quarters
+1 vs previous quarter over the last 8.
14132024Q12025Q4
Price is +23.6% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

25 events
  1. +114,541 shares · 2025Q4
    13F
  2. −60,980 shares · 2025Q4
    13F
  3. −295,494 shares · 2025Q4
    13F
  4. +95,688 shares · 2025Q4
    13F
  5. −323,321 shares · 2025Q4
    13F
  6. −7,010 shares · 2025Q4
    13F
  7. +975,389 shares · 2025Q4
    13F
  8. −461,870 shares · 2025Q4
    13F
  9. +16,044 shares · 2025Q4
    13F
  10. −175,931 shares · 2025Q4
    13F
  11. −11,713 shares · 2025Q4
    13F
  12. −165,129 shares · 2025Q4
    13F
  13. −179,084 shares · 2025Q3
    13F
  14. −2,680,141 shares · 2025Q3
    13F
  15. −1,445,720 shares · 2025Q3
    13F
  16. +238,187 shares · 2025Q3
    13F
  17. +131,406 shares · 2025Q3
    13F
  18. +14,709 shares · 2025Q3
    13F
  19. +6,752 shares · 2025Q3
    13F
  20. −149,009 shares · 2025Q3
    13F
  21. −386,200 shares · 2025Q3
    13F
  22. −111,152 shares · 2025Q3
    13F
  23. +411,503 shares · 2025Q3
    13F
  24. −149,793 shares · 2025Q3
    13F
  25. −39,735 shares · 2024Q3
    13F

Insider activity

No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of BCRX…
Cost basis inferred from 13F share-delta history. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
T. Rowe Price2017Q3$0.17+5648.2%$1.7M
Paul Tudor Jones (Tudor Investment)2016Q1$6.64+43.4%$1.1M
Wellington Management2016Q1$6.67+42.8%$824K
AQR Capital Management2016Q1$6.94+37.2%$6.7M
Renaissance Technologies2016Q1$7.08+34.5%$20.3M
Izzy Englander (Millennium Mgmt)2016Q1$7.56+26.0%$1.3M
Ray Dalio (Bridgewater Associates)2025Q3$7.59+25.4%$2.2M
Steve Cohen (Point72)2017Q4$7.66+24.3%$11.6M
Ken Griffin (Citadel Advisors)2016Q3$7.80+22.1%$12.4M
Ken Griffin (Citadel Advisors)2016Q3$7.80+22.1%$12.4M
Ken Griffin (Citadel Advisors)2016Q3$7.80+22.1%$12.4M
Two Sigma Investments2016Q4$7.84+21.4%$43.0M
D.E. Shaw & Co.2016Q1$8.38+13.7%$11.9M
Ken Fisher (Fisher Asset Mgmt)2021Q2$12.96-26.5%$23.5M

Who moved on this name in 2025Q4

13F transactions reported for the latest quarter, grouped by direction.
New positions1
Added to3
Exited0

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
13
$13.27B
2022Q2
14
$21.25B
2022Q3
14
$13.8M
2022Q4
14
$230.6M
2023Q1
15
$193.2M
2023Q2
14
$234.1M
2023Q3
14
$231.0M
2023Q4
13
$179.9M
2024Q1
13
$144.5M
2024Q2
13
$182.2M
2024Q3
13
$71.5M
2024Q4
12
$64.7M
2025Q1
12
$99.2M
2025Q2
14
$181.3M
2025Q3
13
$110.9M
2025Q4
14
$112.0M
Congress members trading this stock
DateMemberTypeAmount rangeFiling
2025-11-13Gilbert CisnerosBuy$1K – $15KPDF ↗

Who owns BCRX

14 super-investors · 2025Q4
Tracked stake
14.54M
shares
Combined value
$112M
% of shares outstanding
shares-out unknown
Quarter action mix
New1Added3Trim10
#ManagerSharesValue
1Two Sigma Investments4.52M$35M
2Ken Fisher
Fisher Asset Mgmt
2.47M$19M
3Renaissance Technologies2.13M$17M
4Ken Griffin
Citadel Advisors
1.30M$10M
5D.E. Shaw & Co.1.25M$10M
6Steve Cohen
Point72
1.21M$9M
7AQR Capital Management704.3K$5M
8Ray Dalio
Bridgewater Associates
235.6K$2M
9Izzy Englander
Millennium Mgmt
137.6K$1M
10Ken Griffin
Citadel Advisors
131.7K$1M
11Paul Tudor Jones
Tudor Investment
114.5K$893K
12Wellington Management86.5K$675K
13Ken Griffin
Citadel Advisors
81.6K$636K
14T. Rowe Price177.4K$1K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live BCRX chart.
<iframe src="https://openstocks.me/embed/stock/BCRX" width="100%" height="480" frameborder="0" loading="lazy" title="BCRX chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>